Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Harvard Business School
Merck
Accenture
Moodys
Cantor Fitzgerald
Federal Trade Commission
Farmers Insurance
Argus Health
UBS

Generated: October 17, 2017

DrugPatentWatch Database Preview

TRIAMCINOLONE ACETONIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for triamcinolone acetonide and what is the scope of triamcinolone acetonide freedom to operate?

Triamcinolone acetonide
is the generic ingredient in twenty-four branded drugs marketed by Mylan Pharms Inc, Apothecon, Delcor Asset Corp, Taro, Parnell, Perrigo Israel, Ranbaxy Labs Ltd, Teligent Pharma Inc, Teva, Pharmafair, Akorn, Solvay, Perrigo New York, Alpharma Us Pharms, Astellas, Abbvie, Glenmark Pharms Ltd, Allergan, Glenmark Pharms, Lupin Atlantis, Watson Labs, G And W Labs Inc, Ivax Pharms, Ambix, Crown Labs, Novartis Pharms Corp, Wockhardt Eu Operatn, Wockhardt, Sandoz Inc, Fougera Pharms, Sanofi Aventis Us, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Riconpharma Llc, Pharmaderm, Morton Grove, Savage Labs, G And W Labs, Cmp Pharma Inc, and Actavis Mid Atlantic, and is included in one hundred and twenty-one NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has sixty-one patent family members in thirty-two countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Eighty-five suppliers are listed for this compound.

Summary for Generic Name: TRIAMCINOLONE ACETONIDE

US Patents:6
Tradenames:24
Applicants:42
NDAs:121
Drug Master File Entries: see list51
Suppliers / Packagers: see list85
Bulk Api Vendors: see list49
Clinical Trials: see list266
Patent Applications: see list5,752
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:TRIAMCINOLONE ACETONIDE at DailyMed

Pharmacology for Ingredient: TRIAMCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL086276-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Delcor Asset Corp
KENALOG
triamcinolone acetonide
CREAM;TOPICAL083943-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 2013OTCYesYes► Subscribe► SubscribeY ► Subscribe
Teligent Pharma Inc
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
LOTION;TOPICAL204606-001Jul 7, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Savage Labs
TRYMEX
triamcinolone acetonide
CREAM;TOPICAL088198-001Mar 25, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Savage Labs
TRYMEX
triamcinolone acetonide
OINTMENT;TOPICAL088693-001Aug 2, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL011601-003Approved Prior to Jan 1, 1982ATRXYesNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT
triamcinolone acetonide
OINTMENT;TOPICAL080745-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Akorn
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
PASTE;DENTAL206312-001Aug 11, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Pharms
TRIATEX
triamcinolone acetonide
CREAM;TOPICAL087428-001Nov 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
Sanofi Aventis Us
NASACORT
triamcinolone acetonide
AEROSOL, METERED;NASAL019798-001Jul 11, 1991► Subscribe► Subscribe
Abbvie
AZMACORT
triamcinolone acetonide
AEROSOL, METERED;INHALATION018117-001Apr 23, 1982► Subscribe► Subscribe
Delcor Asset Corp
KENALOG-H
triamcinolone acetonide
CREAM;TOPICAL086240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
Sanofi Aventis Us
NASACORT ALLERGY 24 HOUR
triamcinolone acetonide
SPRAY, METERED;NASAL020468-002Oct 11, 2013► Subscribe► Subscribe
Abbvie
AZMACORT
triamcinolone acetonide
AEROSOL, METERED;INHALATION018117-001Apr 23, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: triamcinolone acetonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,375,984 Aqueous-based pharmaceutical composition► Subscribe
7,122,206Aqueous-based pharmaceutical composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: triamcinolone acetonide

Country Document Number Estimated Expiration
South Korea20000023563► Subscribe
Hong Kong1146464► Subscribe
China101959519► Subscribe
Slovakia181698► Subscribe
Hong Kong1022652► Subscribe
African Regional IP Organization (ARIPO)1045► Subscribe
Slovakia284491► Subscribe
Uruguay31699► Subscribe
World Intellectual Property Organization (WIPO)2009114521► Subscribe
South Africa9705947► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Farmers Insurance
Healthtrust
McKinsey
Deloitte
Merck
UBS
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot